Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹48.32, the stock trades at a trailing P/E ratio of 15.1x. Average trailing P/E is 20x in the Metals and Mining industry in India. Total returns to shareholders of 33% over the past year. 공고 • Aug 04
Mardia Samyoung Capillary Tubes Company Limited to Report Q1, 2027 Results on Aug 11, 2026 Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q1, 2027 results on Aug 11, 2026 Valuation Update With 7 Day Price Move • Jun 09
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₹50.25, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 21x in the Metals and Mining industry in India. Total returns to shareholders of 397% over the past year. Board Change • Jun 01
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Chairman Ravindra Mardia is the most experienced director on the board, commencing their role in 1992. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. New Risk • May 14
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 177% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (177% accrual ratio). Market cap is less than US$10m (₹444.3m market cap, or US$4.64m). 공고 • May 07
Mardia Samyoung Capillary Tubes Company Limited to Report Q4, 2026 Results on May 12, 2026 Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q4, 2026 results on May 12, 2026 공고 • Jan 20
Mardia Samyoung Capillary Tubes Company Limited to Report Q3, 2026 Results on Jan 24, 2026 Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Jan 24, 2026 Reported Earnings • Nov 17
Second quarter 2026 earnings released Second quarter 2026 results: EPS: ₹0.02. Net income: ₹172.0k (up ₹14.4m from 2Q 2025). New Risk • Nov 17
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 64% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (64% accrual ratio). Revenue is less than US$1m (₹4.1m revenue, or US$46k). Market cap is less than US$10m (₹850.7m market cap, or US$9.60m). 공고 • Nov 08
Mardia Samyoung Capillary Tubes Company Limited to Report Q2, 2026 Results on Nov 11, 2025 Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q2, 2026 results on Nov 11, 2025 Board Change • Oct 01
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Chairman Ravindra Mardia is the most experienced director on the board, commencing their role in 1992. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. 공고 • Sep 23
Mardia Samyoung Capillary Tubes Company Limited Approves Appointment of Ms. Sonal Vaghelaas Independent Director Mardia Samyoung Capillary Tubes Company Limited approved appointment of Ms. Sonal Vaghela (as Independent Director of the Company. 공고 • Sep 01
Mardia Samyoung Capillary Tubes Company Limited, Annual General Meeting, Sep 21, 2025 Mardia Samyoung Capillary Tubes Company Limited, Annual General Meeting, Sep 21, 2025, at 14:00 Indian Standard Time. Board Change • Sep 01
High number of new and inexperienced directors There are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. 1 highly experienced director. Chairman Ravindra Mardia is the most experienced director on the board, commencing their role in 1992. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. 공고 • Aug 05
Mardia Samyoung Capillary Tubes Company Limited to Report Q1, 2026 Results on Aug 12, 2025 Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q1, 2026 results on Aug 12, 2025 Valuation Update With 7 Day Price Move • Jul 08
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to ₹24.04, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 24x in the Metals and Mining industry in India. Board Change • Jul 08
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Chairman Ravindra Mardia is the most experienced director on the board, commencing their role in 1992. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Jun 24
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹12.14, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 22x in the Metals and Mining industry in India. Board Change • Jun 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 공고 • May 22
Mardia Samyoung Capillary Tubes Company Limited to Report Fiscal Year 2025 Results on May 30, 2025 Mardia Samyoung Capillary Tubes Company Limited announced that they will report fiscal year 2025 results on May 30, 2025 Board Change • Mar 17
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Mar 03
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 공고 • Feb 11
Mardia Samyoung Capillary Tubes Company Limited to Report Q3, 2025 Results on Feb 14, 2025 Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q3, 2025 results on Feb 14, 2025 Board Change • Jan 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Jan 13
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Dec 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 공고 • Oct 15
Mardia Samyoung Capillary Tubes Company Limited to Report Q2, 2025 Results on Oct 25, 2024 Mardia Samyoung Capillary Tubes Company Limited announced that they will report Q2, 2025 results on Oct 25, 2024 Board Change • Sep 09
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Non-Independent Director Preeti Rawat was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.